{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T22:19:25Z","timestamp":1768774765982,"version":"3.49.0"},"reference-count":44,"publisher":"China Science Publishing & Media Ltd.","issue":"1","license":[{"start":{"date-parts":[[2018,12,19]],"date-time":"2018-12-19T00:00:00Z","timestamp":1545177600000},"content-version":"vor","delay-in-days":18,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation","doi-asserted-by":"crossref","award":["81673443"],"award-info":[{"award-number":["81673443"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["engine.scichina.com"],"crossmark-restriction":false},"short-container-title":["ABBS"],"published-print":{"date-parts":[[2018,12,1]]},"DOI":"10.1093\/abbs\/gmy152","type":"journal-article","created":{"date-parts":[[2018,11,5]],"date-time":"2018-11-05T12:09:24Z","timestamp":1541419764000},"page":"20-30","update-policy":"https:\/\/doi.org\/10.1360\/scp-crossmark-policy-page","source":"Crossref","is-referenced-by-count":13,"title":["AdipoRon prevents -thyroxine or isoproterenol-induced cardiac hypertrophy through regulating the AMPK-related pathway"],"prefix":"10.3724","volume":"51","author":[{"given":"Xinlei","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiong","family":"Ou-Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lanlan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxue","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2026","published-online":{"date-parts":[[2018,12,19]]},"reference":[{"key":"null","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1007\/s00204-015-1477-x","volume":"89","author":"Tham YK","year":"2015","unstructured":"Tham YK, Bernardo BC, Ooi JY, Weeks KL, McMullen JR. Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets. Arch Toxicol, 2015, 89: 1401-1438.","journal-title":"Arch Toxicol"},{"key":"null","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.pharmthera.2012.06.006","volume":"135","author":"Hou J","year":"2012","unstructured":"Hou J, Kang YJ. Regression of pathological cardiac hypertrophy: signaling pathways and therapeutic targets. Pharmacol Ther, 2012, 135: 337-354.","journal-title":"Pharmacol Ther"},{"key":"null","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s10741-007-9007-4","volume":"12","author":"Osadchii OE","year":"2007","unstructured":"Osadchii OE. Cardiac hypertrophy induced by sustained beta-adrenoreceptor activation: pathophysiological aspects. Heart Fail Rev, 2007, 12: 66-86.","journal-title":"Heart Fail Rev"},{"key":"null","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1161\/01.RES.0000256090.42690.05","volume":"100","author":"Towler MC","year":"2007","unstructured":"Towler MC, Hardie DG. AMP-activated protein kinase in metabolic control and insulin signaling. Circ Res, 2007, 100: 328-341.","journal-title":"Circ Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"H87","DOI":"10.1152\/ajpheart.00285.2005","volume":"290","author":"Sambandam N","year":"2006","unstructured":"Sambandam N, Morabito D, Wagg C, Finck BN, Kelly DP, Lopaschuk GD. Chronic activation of PPARalpha is detrimental to cardiac recovery after ischemia. Am J Physiol Heart Circ Physiol, 2006, 290: H87-H95.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"null","doi-asserted-by":"crossref","first-page":"H2677","DOI":"10.1152\/ajpheart.00200.2004","volume":"288","author":"Panagia M","year":"2005","unstructured":"Panagia M, Gibbons GF, Radda GK, Clarke K. PPAR-alpha activation required for decreased glucose uptake and increased susceptibility to injury during ischemia. Am J Physiol Heart Circ Physiol, 2005, 288: H2677-H2683.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"null","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1172\/JCI0214080","volume":"109","author":"Finck BN","year":"2002","unstructured":"Finck BN, Lehman JJ, Leone TC, Welch MJ, Bennett MJ, Kovacs A, Han X. The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus. J Clin Invest, 2002, 109: 121-130.","journal-title":"J Clin Invest"},{"key":"null","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/nm1116","volume":"10","author":"Cheng L","year":"2004","unstructured":"Cheng L, Ding G, Qin Q, Huang Y, Lewis W, He N, Evans RM. Cardiomyocyte-restricted peroxisome proliferator-activated receptor-delta deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy. Nat Med, 2004, 10: 1245-1250.","journal-title":"Nat Med"},{"key":"null","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.bbrc.2003.11.127","volume":"313","author":"Cheng L","year":"2004","unstructured":"Cheng L, Ding G, Qin Q, Xiao Y, Woods D, Chen YE, Yang Q. Peroxisome proliferator-activated receptor delta activates fatty acid oxidation in cultured neonatal and adult cardiomyocytes. Biochem Biophys Res Commun, 2004, 313: 277-286.","journal-title":"Biochem Biophys Res Commun"},{"key":"null","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/S0006-291X(02)02753-5","volume":"299","author":"Hentschke M","year":"2002","unstructured":"Hentschke M, Susens U, Borgmeyer U. PGC-1 and PERC, coactivators of the estrogen receptor-related receptor gamma. Biochem Biophys Res Commun, 2002, 299: 872-879.","journal-title":"Biochem Biophys Res Commun"},{"key":"null","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1161\/CIRCULATIONAHA.107.670588","volume":"115","author":"Finck BN","year":"2007","unstructured":"Finck BN, Kelly DP. Peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) regulatory cascade in cardiac physiology and disease. Circulation, 2007, 115: 2540-2548.","journal-title":"Circulation"},{"key":"null","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1172\/JCI10268","volume":"106","author":"Lehman JJ","year":"2000","unstructured":"Lehman JJ, Barger PM, Kovacs A, Saffitz JE, Medeiros DM, Kelly DP. Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis. J Clin Invest, 2000, 106: 847-856.","journal-title":"J Clin Invest"},{"key":"null","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1128\/MCB.20.5.1868-1876.2000","volume":"20","author":"Vega RB","year":"2000","unstructured":"Vega RB, Huss JM, Kelly DP. The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes. Mol Cell Biol, 2000, 20: 1868-1876.","journal-title":"Mol Cell Biol"},{"key":"null","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0092-8674(03)00269-1","volume":"113","author":"Wang YX","year":"2003","unstructured":"Wang YX, Lee CH, Tiep S, Yu RT, Ham J, Kang H, Evans RM. Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity. Cell, 2003, 113: 159-170.","journal-title":"Cell"},{"key":"null","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1210\/me.2003-0151","volume":"17","author":"Dressel U","year":"2003","unstructured":"Dressel U, Allen TL, Pippal JB, Rohde PR, Lau P, Muscat GE. The peroxisome proliferator-activated receptor beta\/delta agonist, GW501516, regulates the expression of genes involved in lipid catabolism and energy uncoupling in skeletal muscle cells. Mol Endocrinol, 2003, 17: 2477-2493.","journal-title":"Mol Endocrinol"},{"key":"null","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1161\/01.RES.0000060700.55247.7C","volume":"92","author":"Gilde AJ","year":"2003","unstructured":"Gilde AJ, van der Lee KA, Willemsen PH, Chinetti G, van der Leij FR, van der Vusse GJ, Staels B. Peroxisome proliferator-activated receptor (PPAR) alpha and PPARbeta\/delta, but not PPARgamma, modulate the expression of genes involved in cardiac lipid metabolism. Circ Res, 2003, 92: 518-524.","journal-title":"Circ Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1161\/CIRCRESAHA.109.211797","volume":"106","author":"Tao L","year":"2010","unstructured":"Tao L, Wang Y, Gao E, Zhang H, Yuan Y, Lau WB, Chan L. Adiponectin: an indispensable molecule in rosiglitazone cardioprotection following myocardial infarction. Circ Res, 2010, 106: 409-417.","journal-title":"Circ Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"40265","DOI":"10.1074\/jbc.M206324200","volume":"277","author":"Huss JM","year":"2002","unstructured":"Huss JM, Kopp RP, Kelly DP. Peroxisome proliferator-activated receptor coactivator-1alpha (PGC-1alpha) coactivates the cardiac-enriched nuclear receptors estrogen-related receptor-alpha and -gamma. Identification of novel leucine-rich interaction motif within PGC-1alpha. J Biol Chem, 2002, 277: 40265-40274.","journal-title":"J Biol Chem"},{"key":"null","doi-asserted-by":"crossref","first-page":"9013","DOI":"10.1074\/jbc.M212923200","volume":"278","author":"Schreiber SN","year":"2003","unstructured":"Schreiber SN, Knutti D, Brogli K, Uhlmann T, Kralli A. The transcriptional coactivator PGC-1 regulates the expression and activity of the orphan nuclear receptor estrogen-related receptor alpha (ERRalpha). J Biol Chem, 2003, 278: 9013-9018.","journal-title":"J Biol Chem"},{"key":"null","doi-asserted-by":"crossref","first-page":"9079","DOI":"10.1128\/MCB.24.20.9079-9091.2004","volume":"24","author":"Huss JM","year":"2004","unstructured":"Huss JM, Torra IP, Staels B, Gigu\u00e8re V, Kelly DP. Estrogen-related receptor alpha directs peroxisome proliferator-activated receptor alpha signaling in the transcriptional control of energy metabolism in cardiac and skeletal muscle. Mol Cell Biol, 2004, 24: 9079-9091.","journal-title":"Mol Cell Biol"},{"key":"null","doi-asserted-by":"crossref","first-page":"10684","DOI":"10.1128\/MCB.25.24.10684-10694.2005","volume":"25","author":"Wende AR","year":"2005","unstructured":"Wende AR, Huss JM, Schaeffer PJ, Gigu\u00e8re V, Kelly DP. PGC-1alpha coactivates PDK4 gene expression via the orphan nuclear receptor ERRalpha: a mechanism for transcriptional control of muscle glucose metabolism. Mol Cell Biol, 2005, 25: 10684-10694.","journal-title":"Mol Cell Biol"},{"key":"null","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1172\/JCI9056","volume":"105","author":"Barger PM","year":"2000","unstructured":"Barger PM, Brandt JM, Leone TC, Weinheimer CJ, Kelly DP. Deactivation of peroxisome proliferator-activated receptor-alpha during cardiac hypertrophic growth. J Clin Invest, 2000, 105: 1723-1730.","journal-title":"J Clin Invest"},{"key":"null","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1038\/sj.emboj.7600351","volume":"23","author":"Sano M","year":"2004","unstructured":"Sano M, Wang SC, Shirai M, Scaglia F, Xie M, Sakai S, Tanaka T. Activation of cardiac Cdk9 represses PGC-1 and confers a predisposition to heart failure. EMBO J, 2004, 23: 3559-3569.","journal-title":"EMBO J"},{"key":"null","doi-asserted-by":"crossref","first-page":"10086","DOI":"10.1073\/pnas.0603615103","volume":"103","author":"Arany Z","year":"2006","unstructured":"Arany Z, Novikov M, Chin S, Ma Y, Rosenzweig A, Spiegelman BM. Transverse aortic constriction leads to accelerated heart failure in mice lacking PPAR-gamma coactivator 1alpha. Proc Natl Acad Sci USA, 2006, 103: 10086-10091.","journal-title":"Proc Natl Acad Sci USA"},{"key":"null","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1161\/HYPERTENSIONAHA.111.174128","volume":"58","author":"Hu X","year":"2011","unstructured":"Hu X, Xu X, Lu Z, Zhang P, Fassett J, Zhang Y, Xin Y. AMP activated protein kinase-alpha2 regulates expression of estrogen-related receptor-alpha, a metabolic transcription factor related to heart failure development. Hypertension, 2011, 58: 696-703.","journal-title":"Hypertension"},{"key":"null","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.yjmcc.2008.10.025","volume":"46","author":"Sihag S","year":"2009","unstructured":"Sihag S, Cresci S, Li AY, Sucharov CC, Lehman JJ. PGC-1alpha. and ERRalpha target gene downregulation is a signature of the failing human heart. J Mol Cell Cardiol, 2009, 46: 201-212.","journal-title":"J Mol Cell Cardiol"},{"key":"null","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1038\/nm1137","volume":"10","author":"Shibata R","year":"2004","unstructured":"Shibata R, Ouchi N, Ito M, Kihara S, Shiojima I, Pimentel DR, Kumada M. Adiponectin-mediated modulation of hypertrophic signals in the heart. Nat Med, 2004, 10: 1384-1389.","journal-title":"Nat Med"},{"key":"null","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00395-013-0329-1","volume":"108","author":"Yan W","year":"2013","unstructured":"Yan W, Zhang H, Liu P, Wang H, Liu J, Gao C, Liu Y. Impaired mitochondrial biogenesis due to dysfunctional adiponectin-AMPK-PGC-1alpha signaling contributing to increased vulnerability in diabetic heart. Basic Res Cardiol, 2013, 108:","journal-title":"Basic Res Cardiol"},{"key":"null","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/nature08991","volume":"464","author":"Iwabu M","year":"2010","unstructured":"Iwabu M, Yamauchi T, Okada-Iwabu M, Sato K, Nakagawa T, Funata M, Yamaguchi M. Adiponectin and AdipoR1 regulate PGC-1alpha and mitochondria by Ca(2+) and AMPK\/SIRT1. Nature, 2010, 464: 1313-1319.","journal-title":"Nature"},{"key":"null","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nature12656","volume":"503","author":"Okada-Iwabu M","year":"2013","unstructured":"Okada-Iwabu M, Yamauchi T, Iwabu M, Honma T, Hamagami K, Matsuda K, Yamaguchi M. A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity. Nature, 2013, 503: 493-499.","journal-title":"Nature"},{"key":"null","doi-asserted-by":"crossref","first-page":"E275","DOI":"10.1152\/ajpendo.00577.2014","volume":"309","author":"Zhang Y","year":"2015","unstructured":"Zhang Y, Zhao J, Li R, Lau WB, Yuan YX, Liang B, Li R. AdipoRon, the first orally active adiponectin receptor activator, attenuates postischemic myocardial apoptosis through both AMPK-mediated and AMPK-independent signalings. Am J Physiol Endocrinol Metab, 2015, 309: E275-E282.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"null","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.phrs.2017.02.016","volume":"119","author":"Fairaq A","year":"2017","unstructured":"Fairaq A, Shawky NM, Osman I, Pichavaram P, Segar L. AdipoRon, an adiponectin receptor agonist, attenuates PDGF-induced VSMC proliferation through inhibition of mTOR signaling independent of AMPK: implications toward suppression of neointimal hyperplasia. Pharmacol Res, 2017, 119: 289-302.","journal-title":"Pharmacol Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1681\/ASN.2017060627","volume":"29","author":"Kim Y","year":"2018","unstructured":"Kim Y, Lim JH, Kim MY, Kim EN, Yoon HE, Shin SJ, Choi BS. The adiponectin receptor agonist AdipoRon ameliorates diabetic nephropathy in a model of Type 2 Diabetes. J Am Soc Nephrol, 2018, 29: 1108-1127.","journal-title":"J Am Soc Nephrol"},{"key":"null","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1172\/JCI62839","volume":"123","author":"van Berlo JH","year":"2013","unstructured":"van Berlo JH, Maillet M, Molkentin JD. Signaling effectors underlying pathologic growth and remodeling of the heart. J Clin Invest, 2013, 123: 37-45.","journal-title":"J Clin Invest"},{"key":"null","first-page":"97","volume":"26","author":"Weeks KL","year":"2011","unstructured":"Weeks KL, McMullen JR. The athlete\u2019s heart vs. the failing heart: can signaling explain the two distinct outcomes?. Physiology (Bethesda), 2011, 26: 97-105.","journal-title":"Physiology (Bethesda)"},{"key":"null","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S0140-6736(06)68074-4","volume":"367","author":"Opie LH","year":"2006","unstructured":"Opie LH, Commerford PJ, Gersh BJ, Pfeffer MA. Controversies in ventricular remodelling. Lancet, 2006, 367: 356-367.","journal-title":"Lancet"},{"key":"null","doi-asserted-by":"crossref","first-page":"H1898","DOI":"10.1152\/ajpheart.00740.2006","volume":"292","author":"Osadchii OE","year":"2007","unstructured":"Osadchii OE, Norton GR, McKechnie R, Deftereos D, Woodiwiss AJ. Cardiac dilatation and pump dysfunction without intrinsic myocardial systolic failure following chronic beta-adrenoreceptor activation. Am J Physiol Heart Circ Physiol, 2007, 292: H1898-H1905.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"null","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.pharmthera.2010.04.005","volume":"128","author":"Bernardo BC","year":"2010","unstructured":"Bernardo BC, Weeks KL, Pretorius L, McMullen JR. Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies. Pharmacol Ther, 2010, 128: 191-227.","journal-title":"Pharmacol Ther"},{"key":"null","first-page":"1473","volume":"56","author":"Istr\u0103toaie O","year":"2015","unstructured":"Istr\u0103toaie O, Ofi\u0162eru AM, Nicola GC, Radu RI, Florescu C, Mogoant\u0103 L, Streba CT. Myocardial interstitial fibrosis\u2014histological and immunohistochemical aspects. Rom J Morphol Embryol, 2015, 56: 1473-1480.","journal-title":"Rom J Morphol Embryol"},{"key":"null","doi-asserted-by":"crossref","first-page":"e22391","DOI":"10.1371\/journal.pone.0022391","volume":"6","author":"Park JY","year":"2011","unstructured":"Park JY, Li W, Zheng D, Zhai P, Zhao Y, Matsuda T, Vatner SF. Comparative analysis of mRNA isoform expression in cardiac hypertrophy and development reveals multiple post-transcriptional regulatory modules. PLoS One, 2011, 6:","journal-title":"PLoS One"},{"key":"null","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1161\/CIRCGENETICS.108.806935","volume":"2","author":"Sheehy SP","year":"2009","unstructured":"Sheehy SP, Huang S, Parker KK. Time-warped comparison of gene expression in adaptive and maladaptive cardiac hypertrophy. Circ Cardiovasc Genet, 2009, 2: 116-124.","journal-title":"Circ Cardiovasc Genet"},{"key":"null","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1172\/JCI17061","volume":"111","author":"Holtwick R","year":"2003","unstructured":"Holtwick R, van Eickels M, Skryabin BV, Baba HA, Bubikat A, Begrow F, Schneider MD. Pressure-independent cardiac hypertrophy in mice with cardiomyocyte-restricted inactivation of the atrial natriuretic peptide receptor guanylyl cyclase-A. J Clin Invest, 2003, 111: 1399-1407.","journal-title":"J Clin Invest"},{"key":"null","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1016\/j.jacc.2010.01.031","volume":"55","author":"McKie PM","year":"2010","unstructured":"McKie PM, Cataliotti A, Lahr BD, Martin FL, Redfield MM, Bailey KR, Rodeheffer RJ. The prognostic value of N-terminal pro-B-type natriuretic peptide for death and cardiovascular events in healthy normal and stage A\/B heart failure subjects. J Am Coll Cardiol, 2010, 55: 2140-2147.","journal-title":"J Am Coll Cardiol"},{"key":"null","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1007\/s00018-016-2407-7","volume":"74","author":"Li T","year":"2017","unstructured":"Li T, Jiang S, Yang Z, Ma Z, Yi W, Wang D, Yang Y. Targeting the energy guardian AMPK: another avenue for treating cardiomyopathy?. Cell Mol Life Sci, 2017, 74: 1413-1429.","journal-title":"Cell Mol Life Sci"}],"container-title":["Acta Biochimica et Biophysica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/engine.scichina.com\/doi\/pdf\/1A63B6497FC4492A8C861D6E3B8ADC02","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/engine.scichina.com\/doi\/10.1093\/abbs\/gmy152","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/engine.scichina.com\/doi\/pdf\/1A63B6497FC4492A8C861D6E3B8ADC02","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T08:21:31Z","timestamp":1662366091000},"score":1,"resource":{"primary":{"URL":"http:\/\/engine.scichina.com\/doi\/10.1093\/abbs\/gmy152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,1]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12,19]]},"published-print":{"date-parts":[[2018,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/abbs\/gmy152","relation":{},"ISSN":["1672-9145"],"issn-type":[{"value":"1672-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12,1]]}}}